Establishing secure connection…Loading editor…Preparing document…

FDA Compliance Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

FDA COMPLIANCE FORM

This FDA Compliance Form (the Agreement) is entered into as of Effective Date: by and between Manufacturer Name: with principal place of business at (Manufacturer), and Distributor/Recipient Name: with principal place of business at (Recipient).

RECITALS

WHEREAS, Manufacturer is engaged in the manufacture, packaging and labeling of the Product described below and represents that such activities occur under quality systems and processes intended to comply with the Federal Food, Drug, and Cosmetic Act and applicable federal regulations, including current Good Manufacturing Practices;

WHEREAS, Recipient intends to distribute, market or otherwise place the Product into interstate commerce and requires documented assurances from Manufacturer concerning regulatory compliance, record accessibility, adverse event reporting and recall cooperation;

WHEREAS, the parties desire to set forth in writing their respective certifications, obligations and procedures to ensure compliance with applicable laws and to allocate responsibilities in the event of nonconformance, recall, or regulatory action;

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows:

1. DEFINITIONS

For purposes of this Agreement, the following terms have the following meanings:

"Product" means the article(s), device(s), drug(s) or combination product(s) subject to this Agreement identified as Product Name: , Product Code / SKU: , and further described as:

2. CERTIFICATIONS AND REPRESENTATIONS

Manufacturer hereby certifies and represents that:

  1. Manufacturing Processes: All manufacture, storage, labeling and distribution of the Product at Manufacturing Location: are conducted in conformity with the Federal Food, Drug, and Cosmetic Act and applicable federal regulations, including current Good Manufacturing Practices (cGMP).
  2. Regulatory Status: To Manufacturer's best knowledge, the Product is not adulterated or misbranded as defined in applicable law, and, where applicable, required premarket notifications, clearances or approvals have been obtained and are summarized here:
  3. Registration and Listing: Manufacturer's establishment registration and product listings, if required, are current and accurate. FDA Establishment/Registration Number (if applicable):

3. MANUFACTURING AND QUALITY OBLIGATIONS

Manufacturer shall manufacture, inspect and release Product lots in accordance with written specifications and quality agreements. Manufacturer shall ensure that each lot bears accurate labeling and lot identification (Lot Number: ; Manufacture Date: ).

Manufacturer confirms the following (check applicable):

4. RECORDS, INSPECTIONS AND AUDIT RIGHTS

Manufacturer shall maintain records, batch production records, test data and distribution records relating to the Product for a period of Records Retention Period (years): years, or such longer period as required by law. Upon reasonable notice, Manufacturer shall permit Recipient, or an independent auditor engaged by Recipient, to inspect relevant records and facilities during normal business hours, subject to customary confidentiality safeguards.

5. ADVERSE EVENTS, COMPLAINTS AND REPORTING

Manufacturer shall notify Recipient within Notification Timeframe (hours): hours of becoming aware of any serious adverse event, reportable complaint, or potential reportable event as defined by applicable law. Manufacturer shall cooperate in preparation and submission of required regulatory reports and provide to Recipient copies of all communications with regulatory authorities concerning the Product.

6. RECALLS AND CORRECTIVE ACTIONS

In the event that Product is or may be the subject of a recall, market withdrawal, or correction, the parties shall cooperate fully. Manufacturer shall promptly notify Recipient of a recall scenario and, unless otherwise agreed in writing, Manufacturer shall be responsible for execution of the recall or corrective action plan and associated costs to the extent caused by Manufacturer's nonconformity. The parties agree to coordinate communications to regulators and the public so as to ensure consistency and regulatory compliance.

7. INDEMNIFICATION

Manufacturer shall indemnify, defend and hold harmless Recipient and its officers, directors and agents from and against any third party claims, liabilities, losses, damages, costs and expenses (including reasonable attorneys' fees) arising out of Manufacturer's breach of its warranties or obligations under this Agreement, negligent acts or omissions, or failure to comply with applicable law. Indemnity Limit (if any): .

8. CONFIDENTIALITY

Unless otherwise agreed in a separate confidentiality agreement, each party shall treat as confidential all non-public information disclosed by the other party in connection with this Agreement, including quality and manufacturing records, and shall not disclose such information except as required by law or to its professional advisors bound by confidentiality obligations.

9. TERM AND TERMINATION

This Agreement shall commence on the Effective Date and continue until terminated by either party upon Termination Notice Period (days): days' written notice. Either party may terminate immediately for cause if the other party materially breaches its obligations and fails to cure within Cure Period (days): days after written notice.

10. NOTICES

All notices shall be in writing and delivered by certified mail, courier, or email to the addresses set forth above, and shall be effective upon receipt.

11. AMENDMENTS; WAIVER; COUNTERPARTS

No amendment or modification of this Agreement shall be effective unless in writing and signed by authorized representatives of both parties. Failure to enforce any provision shall not constitute a waiver of that provision. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.

12. GOVERNING LAW; ENTIRE AGREEMENT; SEVERABILITY

This Agreement shall be governed by and construed in accordance with the laws of the State of , without regard to its conflict of laws rules. This Agreement, together with any exhibits or attachments, constitutes the entire agreement between the parties relating to its subject matter and supersedes all prior proposals and agreements. If any provision of this Agreement is held invalid or unenforceable, the remainder of the Agreement shall remain in full force and effect.

13. MISCELLANEOUS PROVISIONS

Each party shall perform its obligations hereunder in a manner consistent with applicable law and applicable regulatory guidance. Neither party shall assign this Agreement without the prior written consent of the other, except to a successor in interest in connection with a merger or sale of substantially all assets.

SIGNATURES

Manufacturer:

By:

Date:

Recipient:

By:

Date:

Enter text✕

What the FDA Compliance Form is and when to use it

The FDA Compliance Form is a structured record used by regulated organizations to document actions, findings, and attestations that relate to U.S. Food and Drug Administration (FDA) requirements. Typical uses include documenting quality system checks, adverse event reports, corrective and preventive actions (CAPA) logs, device complaint investigations, and vendor qualification evidence. The form is intended to capture discrete data fields, time stamps, responsible parties, and attachments so records meet auditability expectations under 21 CFR Part 11 and broader electronic signature law such as the ESIGN Act (15 U.S.C. ch. 96) and state UETA statutes.

Why a formal FDA Compliance Form matters

A clear compliance form centralizes required information, preserves an auditable record, and reduces inspection risk. Proper formatting and retention support regulatory traceability under 21 CFR Part 11 and ensure that electronic signatures meet ESIGN/UETA legal tests.

Why a formal FDA Compliance Form matters

Who completes and relies on an FDA Compliance Form

External auditors, notified bodies, and the FDA may review these records during inspections or as part of postmarket surveillance reporting.

  • Quality Assurance specialists who document investigations, CAPA, and control verification steps.
  • Regulatory Affairs staff preparing submissions, responses to FDA inquiries, and inspection packages.
  • Operations or manufacturing leads who record batch events, deviations, and vendor acceptance testing.

Core components of a professional FDA Compliance Form

A well-constructed form organizes data for inspections and internal review. It combines fixed fields, conditional sections, attachments, and an electronic audit trail so reviewers can reproduce the event chronology and responsible actors.

Identification

Unique form ID, product or device name, model and lot/serial number for traceability across systems and audits.

Event Details

Concise description of the observed issue, deviation, or investigation summary with fields for root cause, impact, and corrective action plan.

Responsible Parties

Named roles and contact information for persons accountable, with signer roles designated for review, approval, and verification steps.

Dates and Times

Standardized MM/DD/YYYY and time stamps for occurrence, report creation, approvals, and any escalation milestones.

Supporting Evidence

File attachments such as lab reports, batch records, photos, or logs stored in original format and linked to the form entry.

Audit Trail

Immutable activity log including timestamps, IP addresses, and identity evidence to meet 21 CFR Part 11 auditability expectations.

Required fields and essential data elements

Patient/Subject ID: Unique identifier
Product Lot/Serial: Lot or serial
Event Description: Short summary
Responsible Party: Name and role
Date/Time Stamp: MM/DD/YYYY time
Supporting Files: Attachment links

Step-by-step: completing the FDA Compliance Form

Follow a consistent sequence to ensure completeness and defensible records: identify, describe, attach evidence, assign responsibility, then approve with an auditable signature.

  • 01
    1. Identify: Select form type, product, and lot/serial.
  • 02
    2. Describe: Enter concise facts and observed impact.
  • 03
    3. Attach: Upload supporting documents and photos.
  • 04
    4. Review & Sign: Designated reviewer approves with compliant e-signature.

Configuring an online workflow for the form

Design approval routing, authentication, and attachments so each form instance follows the same controlled path from creation through closure.

Field Configuration
Routing Order Sequential or parallel reviewers
Authentication Method Email, SMS, or advanced ID
Required Attachments Specify file types and max size
Retention Labeling Apply record class and retention

Where to file and how to submit completed forms

Submission depends on purpose: internal quality systems retain the record; regulatory submissions follow FDA-specific channels when required.

  • Internal QMS: Store in controlled document repository.
  • FDA Submissions: Use FDA electronic gateway when regulation requires.
  • Third-Party Labs: Share directly with secure links and attachments.
  • Inspection Package: Bundle forms, attachments, and audit logs for review.

Digital signing and technical distribution considerations

Confirm the solution provides an immutable audit trail, strong encryption in transit and at rest, and the ability to export human-readable records for inspections.

  • File Formats: PDF, DOCX, and original lab files
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Authentication: Email, SMS, KBA, or SSO

Timelines and reporting triggers to watch

Deadlines depend on the regulation and event type. Use precise regulatory citations to determine whether an event must be reported or retained by a specific date.

Adverse Event Reporting:

Follow applicable FDA rule (e.g., Medical Device Reporting under 21 CFR Part 803).

Corrective Actions:

Track CAPA target dates and closure evidence in the form.

Inspection Response:

Provide requested records within the period specified by the inspection notice.

Regulatory Submission:

Submit through FDA portals when the regulation requires electronic filing.

Retention Start:

Retention generally begins on the form's effective or creation date.

Common mistakes to avoid when preparing the form

  • Omitting unique identifiers such as lot or serial numbers which prevents traceability during investigations.
  • Using inconsistent date formats or failing to record exact timestamps, complicating timeline reconstruction for audits.
  • Attaching files without descriptive filenames or metadata, making it difficult to link evidence to the event.
  • Allowing signer names to differ from ID or role records, undermining attribution and electronic signature validity.

Consequences of incomplete or incorrect records

Regulatory Action: FDA warning letter
Product Recall: Field correction or recall
Financial Penalties: Civil fines
Criminal Liability: Willful violations possible
Operational Disruption: Production stoppage
Reputational Harm: Loss of customer trust

Real-world examples of form usage and outcomes

These short case narratives show how organizations use structured compliance forms to manage regulatory obligations and inspections.

Fertility Center Example

A clinical center centralized consent and device logs to a single form for each patient encounter.

  • The record linked batch numbers to outcomes.
  • The organization preserved complete audit trails and reported to regulators without missing attachments, improving inspection readiness and internal traceability.

Enterprise Operations Example

A large distributor standardized complaint intake using the form template.

  • The workflow routed to QA automatically.
  • As a result the company reduced investigation cycle time, maintained consistent corrective action records, and could produce a full inspection package with signed approvals and evidence.

Comparing common eSignature providers for FDA-oriented workflows

Vendor pricing and capabilities vary; the table below compares starting price and core features relevant to regulated workflows. Pricing shown is list monthly starting price billed annually where applicable.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no credit card required Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes (Business Premium) Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

FAQs and troubleshooting for FDA Compliance Forms

Answers to common questions about legal validity, e-signatures, retention, and submission workflows for forms used in FDA-regulated contexts.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users